2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$31.11+$0.14 (+0.45%)
Price as of Jun 23, 2026 4:37 PM EDT- $1.9BMarket Cap
- 167.21%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$31.11+$0.14 (+0.45%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ATP LIFE SCIENCE VENTURES, L.P. | 27.56% | 17.2M | 0 (0.00%) | Mar 31, 2021 |
BLACKROCK FUNDING, INC. /DE | 9.45% | 5.9M | +317,361 (+5.39%) | Dec 31, 2024 |
RTW INVESTMENTS, LP | 9.03% | 5.6M | +76,669 (+1.36%) | Mar 31, 2026 |
BLACKROCK INC. | 8.69% | 5.4M | +1.6M (+28.67%) | Jun 30, 2024 |
BLACKROCK, INC. | 8.65% | 5.4M | +173,160 (+3.22%) | Mar 31, 2026 |
FMR LLC | 8.64% | 5.4M | -217,254 (-4.04%) | Mar 31, 2026 |
LYNX1 CAPITAL MANAGEMENT LP | 7.65% | 4.8M | -641,001 (-13.46%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.69% | 2.3M | +100,703 (+4.38%) | Mar 31, 2026 |
iSHARES TRUST | 3.42% | 2.1M | +80,295 (+3.77%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.48% | 1.5M | -508,620 (-32.97%) | Feb 28, 2026 |
FIDELITY SECURITIES FUND | 1.92% | 1.2M | +384,900 (+32.11%) | Jan 31, 2026 |
SPDR SERIES TRUST | 1.81% | 1.1M | -368,719 (-32.76%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 1.13% | 702,700 | -170,100 (-24.21%) | Jan 31, 2026 |
Federated Hermes Equity Funds | 0.95% | 594,000 | 0 (0.00%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions977.3M (85.35%)
- Mutual Funds141.8M (12.38%)
- Insiders25.9M (2.26%)
- Other0 (0.00%)
Insider Transactions
- 2.26% (25.9M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 8Number of InsiderSelling (last 12 months)
- $72.7MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Kahn Clare | Award | Apr 03, 2026 | $0.00 | 30,782 | $0.00 | 30,782 |
Ticho Barry CHIEF MEDICAL OFFICER | Sell | Apr 01, 2026 | $60,029.08 | 1,838 | $32.66 | 38,864 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 20, 2026 | $292,358.90 | 8,692 | $33.64 | 20,144 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 20, 2026 | $20,679.15 | 601 | $34.41 | 19,543 |
Leggett Thomas Chief Financial Officer | Sell | Mar 18, 2026 | $67,979.70 | 2,173 | $31.28 | 10,381 |
Hoitt Jason Chief Patient Officer | Sell | Mar 18, 2026 | $55,122.06 | 1,762 | $31.28 | 10,445 |
Leggett Thomas Chief Financial Officer | Sell | Mar 18, 2026 | $5,467.67 | 172 | $31.79 | 10,209 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 18, 2026 | $132,080.20 | 4,222 | $31.28 | 29,242 |
Leggett Thomas Chief Financial Officer | Sell | Mar 18, 2026 | $1,215.45 | 37 | $32.85 | 10,172 |
Hoitt Jason Chief Patient Officer | Sell | Mar 18, 2026 | $4,418.64 | 139 | $31.79 | 10,306 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 18, 2026 | $10,617.46 | 334 | $31.79 | 28,908 |
Hoitt Jason Chief Patient Officer | Sell | Mar 18, 2026 | $985.50 | 30 | $32.85 | 10,276 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 18, 2026 | $2,365.20 | 72 | $32.85 | 28,836 |
Leggett Thomas Chief Financial Officer | Sell | Mar 17, 2026 | $41,710.00 | 1,274 | $32.74 | 13,476 |
Hoitt Jason Chief Patient Officer | Sell | Mar 17, 2026 | $33,819.80 | 1,033 | $32.74 | 12,955 |
Leggett Thomas Chief Financial Officer | Sell | Mar 17, 2026 | $30,772.12 | 922 | $33.38 | 12,554 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 17, 2026 | $81,062.75 | 2,476 | $32.74 | 35,255 |
Hoitt Jason Chief Patient Officer | Sell | Mar 17, 2026 | $24,964.80 | 748 | $33.38 | 12,207 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Sell | Mar 17, 2026 | $59,775.34 | 1,791 | $33.38 | 33,464 |
Ticho Barry CHIEF MEDICAL OFFICER | Exempt | Mar 15, 2026 | $0.00 | 13,100 | $0.00 | 13,100 |
Leggett Thomas Chief Financial Officer | Exempt | Mar 15, 2026 | $0.00 | 14,750 | $0.00 | 44,250 |
Hoitt Jason Chief Patient Officer | Exempt | Mar 15, 2026 | $0.00 | 10,000 | $0.00 | 30,000 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Exempt | Mar 15, 2026 | $0.00 | 7,475 | $0.00 | 7,475 |
Ticho Barry CHIEF MEDICAL OFFICER | Exempt | Mar 15, 2026 | $0.00 | 10,000 | $0.00 | 20,000 |
Leggett Thomas Chief Financial Officer | Exempt | Mar 15, 2026 | $0.00 | 14,750 | $0.00 | 14,750 |
Hoitt Jason Chief Patient Officer | Exempt | Mar 15, 2026 | $0.00 | 10,000 | $0.00 | 13,988 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Exempt | Mar 15, 2026 | $0.00 | 6,000 | $0.00 | 12,000 |
Ticho Barry CHIEF MEDICAL OFFICER | Exempt | Mar 15, 2026 | $0.00 | 10,750 | $0.00 | 32,250 |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Exempt | Mar 15, 2026 | $0.00 | 12,000 | $0.00 | 36,000 |
Ticho Barry CHIEF MEDICAL OFFICER | Exempt | Mar 15, 2026 | $0.00 | 13,100 | $0.00 | 32,898 |